NASDAQ

Atea Pharmaceuticals, Inc. (AVIR)

♥ 602 Thanks from members

Live price chart, market sentiment, and community perspectives for Atea Pharmaceuticals, Inc. (NASDAQ: AVIR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Jean-Pierre SommadossiLeadership: Jean-Pierre Sommadossi (CEO)Leadership: Andrew Braun (CMO)Holder: Balsamose CapitalHolder: RA Capital ManagementHolder: FMR LLCAtuvirumabBemnifosbuvir (AT-527)Antiviral Drug Candidates#AVIR stock#Atea Pharmaceuticals#NASDAQ AVIR#Biotech Antivirals#Clinical Research